Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabPier Francesco Ferrucci, Chiara Martinoli, Massimo Guidoboni et al.|Annals of Oncology|2016Cited by 398
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumabPier Francesco Ferrucci, Chiara Martinoli, Paolo A. Ascierto et al.|Annals of Oncology|2017Cited by 50
Efficacy and safety data from elderly patients with pretreated advanced melanoma in the Italian cohort of ipilimumab expanded access programme (EAP).Vanna Chiarion‐Sileni, Paola Queirolo, Jacopo Pigozzo et al.|Journal of Clinical Oncology|2013Cited by 5